Pegapamodutide

Pegapamodutide (LY-2944876) is a dual glucagon and GLP-1 receptor agonist used in metabolic disease research. It is applied in studies investigating mechanisms for glucose control and weight loss, with utility in both in vitro receptor activation assays and in vivo models of type 2 diabetes and obesity.